SCHEMBL7968837

SCHEMBL7968837

O=C(NCC(CCO)c1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.61
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
EPHX2 P34913 3/20 0.57
GAA P10253 2/20 0.50
TACR1 P25103 1/20 0.48
GPR139 Q6DWJ6 1/20 0.47
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
PRKACA P17612 1/20 0.44
CDK8 P49336 1/20 0.44
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
PRKX P51817 1/20 0.44
PRKCQ Q04759 1/20 0.44
ROCK1 Q13464 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ITGAV P06756 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3613003 0.85 MTNR1A (0.49) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL6161768 0.83 NPC1 (0.49) SMN1; SMN2NPC1RAB9AEPHX2GPR139
SCHEMBL5866425 0.83 NPC1 (0.49) SMN1; SMN2NPC1RAB9AEPHX2GPR139
SCHEMBL31530566 0.83 NPC1 (0.73) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL1983010 0.82 NPC1 (0.63) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL14361142 0.82 MTNR1A (0.67) SMN1; SMN2GAAMTNR1AMTNR1B
SCHEMBL8597116 0.81 NPC1 (0.54) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL6203013 0.81 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL1924138 0.79 NPC1 (0.59) SMN1; SMN2NPC1RAB9AEPHX2GAA
SCHEMBL1986644 0.77 NPC1 (0.56) SMN1; SMN2NPC1RAB9AEPHX2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077942-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2001-02-28 EP disclosed
WO-1999059972-A1 CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 1999-11-25 WO disclosed